How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.
Alisson PugliesiZoraida SachettoMarcelo de Medeiros PinheiroGecilmara Salviato PileggiGustavo Sarot Pereira da CunhaFaissal Nemer HajarMaria Luiza Marques Negrisolli CunhaLicia Maria Henrique da MotaClaudia Diniz Lopes MarquesAdriana Maria KakehasiWanda Heloísa Rodrigues FerreiraNafice Costa AraújoAna Paula Monteiro Gomides ReisRejane Maria Rodrigues de Abreu VieiraGilda Aparecida FerreiraAdriana DanowskiViviane Angelina de SouzaDanielle Christinne Soares Egypto de BritoEduardo Dos Santos PaivaJosé Roberto ProvenzaValderílio Feijó AzevedoPublished in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2022)
COnVIDa demonstrated a negative impact on health care access and treatment maintenance of patients living with IMRD during the COVID-19 pandemic. However, it also presented an uptake of telemedicine strategies. Data presented in this study may assist future coping policies.